MATINAS BIOPHARMA HOLDINGS, INC.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -44.4% | -44.4% | -38.0% |
| FY2022 | -57.3% | -57.3% | -46.8% |
| FY2023 | -119.2% | -119.2% | -91.4% |
| FY2024 | -319.5% | -319.5% | -191.8% |
| FY2025 | -214.2% | -214.2% | -143.5% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -44.4% | -44.4% | -38.0% |
| FY2022 | -57.3% | -57.3% | -46.8% |
| FY2023 | -119.2% | -119.2% | -91.4% |
| FY2024 | -319.5% | -319.5% | -191.8% |
| FY2025 | -214.2% | -214.2% | -143.5% |